The Efficacy and Safety of Herbal Medicine Treatment Strategy for Patients With Post-Accident Fatigue

Enrolling by invitation · Not applicable

Conditions studied: Post-traffic Accident Fatigue

In brief

This study is a pragmatic randomized controlled pilot clinical trial aimed at evaluating the efficacy and safety of herbal medicine treatment strategy for patients with post-traffic accident fatigue, using an education-only group as the control.

Key facts

Study ID

NCT07254169

Run by

Jaseng Medical Foundation

People needed

40

Starts

2026-01-13

Expected to finish

2026-12-01

Last updated by the study team

2026-05-28

Who can join

Age: 40 and older, up to 69. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women aged 40 to 69 years.
• Patients who have been in a traffic accident for 12 to 24 weeks.
• Patients with an average score of 4 or higher on the FSS-K questionnaire.
• Participants who voluntarily agreed to participate in the study and signed a consent form.

You may not qualify if…

• Participants diagnosed with and receiving treatment for a specific disease that may cause fatigue (cancer, anemia, thyroid dysfunction, etc.).
• Participants with clinically significant abnormalities in blood tests that may be a major cause of fatigue.
• Participants taking herbal medicine for fatigue relief or have taken health supplements for fatigue relief within the past two weeks.
• Participants with other chronic conditions that may interfere with the treatment effect or interpretation of results: stroke, myocardial infarction, kidney disease, active hepatitis, diabetic neuropathy, dementia, epilepsy, etc.
• Participants currently taking steroids, immunosuppressants, psychiatric medications, or other medications that may affect the study results.
• Participants who are not suitable for herbal medicine treatment. Unsafe: Patients with conditions that may affect drug intake or absorption, those with digestive problems following surgery related to such conditions, or those with severe liver or kidney disease (AST, ALT, γ-GTP, and serum creatinine levels greater than twice the upper limit of normal during screening).
• Are pregnant, planning to become pregnant, breastfeeding, or may be pregnant (e.g., recent missed menstrual periods, irregular menstrual cycles, not using contraception, recently had sexual intercourse, or the investigator determines through medical history that pregnancy is possible).
• Participating in research studies other than observational studies without therapeutic intervention.
• Difficulty completing the consent form.
• Other circumstances in which participation in a clinical trial is deemed difficult by the investigator.

Where it is running

• Jaseng Hospital of Korean Medicine — Seoul, Gangnam-Gu, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.